31
Participants
Start Date
November 1, 2011
Primary Completion Date
June 29, 2012
Study Completion Date
July 26, 2016
Validation of Charter score for the CNS diffusion of antiretroviral drugs
IHFB001 (Neuroplustrois) is a pilot study, phase IV, open-label, multicenter in Ile-de-France region, trying to demonstrate the improvement of cognitive change after treatment characterized by its better diffusion in the central nervous system. The characteristics of the change in treatment are (Cn - Ci) ≥ 3 and Cn ≥ 9, where Cn is the Charter score of the new treatment and Ci the Charter score of the initial treatment.
Centre Hospitalier Marc Jacquet, Melun
Centre Hospitalier Intercommunal de Poissy Germain en Laye, Saint-Germain-en-Laye
Hôpital Mignot Centre Hospitalier de Versailles, Chesnay
Centre Hospitalier de Bligny, Briis-sous-Forges
Hôpital Foch, Suresnes
Institut Hospitalier Franco- Britannique, Levallois-Perret
Hôpital Raymond Poincaré, Garches
Hôpital Delafontaine, Saint-Denis
Hôpital Intercommunal Robert Ballanger, Aulnay-sous-Bois
Hôpital d'Argenteuil, Argenteuil
Centre Hospitalier René Dubois, Pontoise
Centre Hospitalier de Gonesse, Gonesse
Hospital Ambroise Paré Paris
OTHER
Hôpital Franco-Britannique-Fondation Cognacq-Jay
OTHER